PDF) ACTN4 gene amplification is a predictive biomarker for

Prognostic implications of PPL expression in ovarian cancer

Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC

The Expressions and Mechanisms of Sarcomeric Proteins in Cancers

Frontiers Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment

IJMS, Free Full-Text

Prognostic implications of PPL expression in ovarian cancer

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer

Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis - eBioMedicine

The mechanobiome: a goldmine for cancer therapeutics

PDF) Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells

PDF) LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating miR-125a-3p-Mediated ACTN4

Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we? - Boys - 2023 - PROTEOMICS - Wiley Online Library

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer

Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas - Noro - 2022 - Cancer Science - Wiley Online Library

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma - ScienceDirect